The Cooper Companies, Inc. Common Stock

International and currency · Foreign exchange and currency exposure

Exchange rate fluctuations and foreign currency hedges could adversely affect our financial results. As a result of our international operations, currency exchange rate fluctuations may affect our results of operations and financial position.

Market and investment · Interest rate and yield curve risk

We are vulnerable to interest rate risk with respect to our debt. We are subject to interest rate risk in connection with the issuance of variable and fixed-rate debt.

Credit and liquidity · Debt service and covenant compliance

Our credit facilities contain financial and other restrictive covenants that could limit our ability to engage in activities that may be in our long-term best interests. Our failure to comply with those covenants could result in an event of default.

Market position and competition · Industry consolidation and market concentration

CooperVision and CooperSurgical are encountering consolidation in their customer bases and emergence of more centralized large customer groups and retail chains. Due to this trend, global and regional key account customers now represent a larger proportion or concentration of our business.

Market position and competition · Disruptive competitors and new market entrants

Product innovations are important in the industry in which we operate, and we face the risk of product obsolescence if we are unable to develop new products or gain regulatory approvals or certifications or if our competitors introduce new products.

Customer and revenue · Reimbursement and pricing pressure healthcare or insurance

Changes in legislation and government regulation of the health care industry both in the United States and internationally, as well as third-party payors' efforts to control the costs of health care could materially adversely affect our business.

Market position and competition · Pricing pressure and margin compression

Pricing pressure from our competitors, customers and changes in third-party coverage and reimbursement may adversely affect demand for our products and negatively impact our operating results. Competition in our industry has increased as a result of new market entrants, new technologies and as more established companies have intensified competitive pricing pressure.

Core operations · Operational disruption and business continuity

We manage our businesses utilizing multiple complex integrated software and hardware information technology operating systems that are regularly maintained and upgraded; an interruption or disruption to these systems could disrupt our business or force us to incur excessive costs.

Human capital and workforce · Key personnel dependence and succession

If we do not retain our key personnel and attract and retain other highly skilled employees, our business could suffer. The success of our business is heavily dependent on the leadership of our key management personnel.

Core operations · Quality control and product defects

If our manufacturing operations fail to comply with applicable regulations, our manufacturing could be delayed or disrupted, our products could be subject to recall, and sales and profitability could suffer. Our manufacturing operations and processes are required to comply with numerous federal, state and foreign regulatory requirements.

Reputation and brand · Product recalls and public safety

Our products are subject to reporting requirements and recalls, even after receiving regulatory clearance, approval or certification, which could harm our reputation and business. The FDA and similar governmental bodies in other countries have the authority to require the recall of our products.

Reputation and brand · Esg environmental social governance performance

Environmental, social and corporate governance issues, including those related to climate change and sustainability, may have an adverse effect on our business and damage our reputation. Customers, consumers, investors and other stakeholders are increasingly focusing on environmental issues, including climate change, energy and water use, plastic waste and other sustainability concerns.

Economic and market conditions · Economic recession and downturns

Current market conditions and recessionary pressures in one or more of our markets could impact our ability to grow our business. The United States and foreign countries have experienced recessionary pressures and face continued concerns about the systemic impacts of adverse economic conditions and geopolitical issues.

Geopolitical and trade · International conflicts and tensions

A significant portion of our current operations are conducted and located outside the United States. International operations and business expansion plans are subject to numerous additional risks, including international conflicts, acts or threats of war or terrorism may lead to significant market and other disruptions, supply chain interruptions, political and social instability, trade disputes or trade barriers.

Geopolitical and trade · Trade policies tariffs and sanctions

Economic and trade sanctions, including tariff and import/export regulations by the U.S. and foreign governments, could make it more difficult or costly for us to conduct our operations or achieve our business objectives. Changes in import and export policies, including new, increased or retaliatory tariffs, sanctions and countersanctions may disrupt our supply chain.

Legal and litigation · Intellectual property disputes

Our products or processes could be subject to claims of infringement of the intellectual property of others. Our competitors in both the United States and foreign countries may have applied for or obtained patents that will prevent, limit or otherwise interfere with our ability to make and sell our existing and planned products.

Industry regulation · Safety and environmental regulations

We face risks related to environmental, social and governance matters. We and our facilities are subject to a broad range of U.S federal, state, local and foreign environmental laws and requirements.

Industry regulation · Fda drug and device approval

Our failure to comply with regulatory requirements or to receive regulatory clearance, approval or certification for our products or operations could adversely affect our business. Our products and operations are subject to rigorous regulation by the FDA, and numerous other federal, state and foreign governmental authorities.

Industry regulation · Licensing and permits

If we fail to comply with applicable federal, state, local and foreign laboratory licensing requirements, we could lose the ability to perform our genetic tests or experience disruptions to our business. We are subject to the CLIA, a federal law regulating clinical laboratories.

Cybersecurity and data protection · Data privacy and protection regulations

The costs of complying with the requirements of federal, state and foreign laws pertaining to the privacy and security of personal information, including health related information and the potential liability associated with failure to do so could materially adversely affect our business.